Background Bladder cancer (BLCA) is a common cancer associated with an unfavorable
prognosis. Increasing numbers of studies have demonstrated that lipid metabolism affects …

Background Bladder cancer is one of the most prevalent malignancies worldwide. However,
traditional indicators have limited predictive effects on the clinical outcomes of bladder …

Background Bladder cancer (BLCA) represents a highly heterogeneous disease
characterized by distinct histological, molecular, and clinical features, whose tumorigenesis …

Cancer immune plays a critical role in cancer progression. Tumour immunology and
immunotherapy are one of the exciting areas in bladder cancer research. In this study, we …

Background There has been no report of prognostic signature based on immune-related
genes (IRGs). This study aimed to develop an IRG-based prognostic signature that could …

Bladder cancer is one of the most common genitourinary malignant cancers worldwide. Cell
death processes, including apoptosis, ferroptosis, and necrosis, provide novel clinical and …

Abstract Background Bladder cancer (BCa) is one of the important tumors that have been
proven to be treatable with immunotherapy. This study aims to identify and validate a …

Background Changes in lipid metabolism pathways play a major role in colon
carcinogenesis and development. Hence, we conducted a systematic analysis of lipid …

Purpose This study aims to identify potential prognostic biomarkers of bladder cancer (BCa)
based on large-scale multi-omics data and investigate the role of SRC in improving …

Background Accumulating evidences demonstrated tumor microenvironment (TME) of
bladder cancer (BLCA) may play a pivotal role in modulating tumorigenesis, progression …